CeQur SA received CE Mark approval to commercialize its PaQ insulin delivery devices in the European market, the company reported this week.

The PaQ insulin delivery system features a disposable insulin-infuser reservoir attached to a reusable insulin monitor and provides 3 days of continuous basal insulin delivery and on-demand bolus insulin for individuals with Type II diabetes, the company said.